%0 Journal Article
%T 三阴性乳腺癌免疫微环境特征及免疫治疗进展<br>Characteristics of the Immune Microenvironment and Progress in Immunotherapy for Triple-Negative Breast Cancer
%A 贾书韬
%A 周宏宇
%J World Journal of Cancer Research
%P 24-38
%@ 2164-9057
%D 2025
%I Hans Publishing
%R 10.12677/wjcr.2025.151004
%X 三阴性乳腺癌(Triple-Negative Breast Cancer, TNBC)是乳腺癌中最具侵袭性的亚型&#65292;由于缺乏雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2 (HER2)的表达&#65292;治疗选择相对有限&#65292;预后效果较差。肿瘤免疫微环境(TIME)在三阴性乳腺癌的发生发展、侵袭转移过程中起着关键作用&#65292;对患者的预后具有重要的影响。免疫治疗是三阴性乳腺癌的主要治疗手段之一&#65292;针对肿瘤免疫微环境的免疫治疗手段为三阴性乳腺癌的治疗的思路提供了新方向。本文就三阴性乳腺癌的免疫微环境特征及主要免疫治疗进展进行综述。<br>Triple-Negative Breast Cancer (TNBC), the most aggressive subtype of breast cancer, has relatively limited treatment options and poor prognosis due to lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Tumor immune microenvironment (TIME) plays a key role in the occurrence, development, invasion and metastasis of triple-negative breast cancer, and has an important impact on the prognosis of patients. Immunotherapy is one of the main therapeutic methods for triple-negative breast cancer. Immunotherapy targeting the tumor immune microenvironment provides a new direction for the treatment of triple-negative breast cancer. This article reviews the characteristics of the immune microenvironment of triple negative breast cancer and the progress of immunotherapy.
%K 三阴性乳腺癌&#65292
%K 免疫微环境&#65292
%K 免疫治疗<br>Triple Negative Breast Cancer
%K Immune Microenvironment
%K Immunotherapy
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=104813